Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT04724759
This study aims is to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing oral and maxillofacial surgery (OMF) temporomandibular joint (TMJ) surgery.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 2
Boston, Massachusetts, 02114, United States
This study will enroll 60 patients undergoing TMJ surgery at Massachusetts General Hospital. Anesthetic care will be standardized according to current institutional standards of care. Intraoperative clinicians will not be blinded to group assignment. Patients will be randomized to one of two groups:
Both groups employ strategies that are routinely used as part of standard clinical practice for TMJ surgery. Patients will otherwise receive the institutional standards of care for their surgical procedure and perioperative care.
Following intraoperative drug administration patients will be followed until discharge from the PACU to assess study endpoints while in the hospital. At the time of discharge from the PACU, members of the study team will ask the patient to compete a brief survey on their satisfaction with pain management.
Patients in this study will be anticipated to be discharged the same day as the surgical procedure. At the time of hospital or PACU discharge, the patient will be provided with a Medication Diary. This will be used to record pain medication administration in the first 48 hours after surgery, as well as any pain or complication they might experience at home.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in this group will receive an infusion of lidocaine, ketamine, or dexmedetomidine supplemented with other intravenous analgesics and intravenous and inhaled anesthetics, as needed clinically. This includes administration of 5 mcg/kg/min of ketamine plus 0.5 - 1.0 µg/kg/hr of dexmedetomidine (Precedex) as a continuous infusion, started from induction to stop one hour before surgery is anticipated to end.
Other names: Precedex
Time frame: Through in-hospital study completion, an average of 1 day
Pain will be measured using the eleven point (0 to 10) numeric rating scale with higher values representing a worse outcome. Pain scores will be recorded every 15 minutes until discharge from the post-anesthesia care unit (PACU) and at 12 and 24 hours postoperatively. Clinically documented pain scores will be recorded. Our primary outcome will be the worst documented pain score while in the PACU. Additional pain score time points will be evaluated as secondary endpoints.
Time frame: 48 hours postoperatively
Intraoperative and postoperative opioid consumption in the first 12, 24 and 48 hours postoperatively will be evaluated.
Time frame: Through in-hospital study completion, an average of 1 day
Use, dosage and time to use of rescue analgesia in the PACU will be reported.
Time frame: Completed upon the patient reaching PACU Phase I in the hospital, up to approximately 6 hours
Self-report pain satisfaction will be assessed at the time of PACU discharge using the Revised American Pain Society Patient Outcome Questionnaire.
This survey asked patients to grade pain either the pain experienced (graded from a 0-10 scale, 0 bring no pain and 10 being the worst pain possible), pain associated with certain movements (0-10 scale, 0 does not interfere and 10 being completely interferes), pain associated with emotions (0-10 scale, 0 not at all and 10 being extremely), side effects (0-10 scale, 0 none and 10 Severe), pain relief (0-10 scale, 0 no relief and 10 being complete relief), and satisfaction (0-10 scale, 0 extremely dissatisfied and 10 being extremely satisfied).
Time frame: 48 hours postoperatively
The incidence of ileus, nausea/vomiting, and pruritis will be reported.
Time frame: Through in-hospital study completion, an average of 1 day
Length of PACU and hospital stay will be reported.
Time frame: 48 hours postoperatively
The total dose of Percocet used at 24 and 48 hours after surgery will be reported.
Time frame: Through in-hospital study completion, an average of 1 day
Time to Hospital Discharge will be reported.
Massachusetts General Hospital
Other
The Effect of Opioid-Free Anesthesia in TMJ Surgery: A Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05068908
Chronic Pain, Craniomandibular Disorders
Minneapolis, Minnesota, United States
View Trial DetailsNCT07691684
Craniomandibular Disorders, Jaw Diseases
Ramadi, Al Najaf, Iraq
View Trial DetailsNCT07624539
Craniomandibular Disorders, Facial Pain
Steamboat Springs, Colorado, United States
View Trial DetailsNCT05989217
Craniomandibular Disorders, Jaw Diseases
Alfenas, Minas Gerais, Brazil
View Trial Details